Our Partners

RSS Investor Relations and News

  • MYOS RENS Technology Reports a 187% Increase in Net Revenues for the Year Ended December 31, 2019 March 25, 2020
    Closed $1.8 million of financing in a Private Placement on March 5, 2020 Company to Hold Conference Call on Wednesday, March 25, 2020, at 11am ET Conference Call Dial In: 877-407-9120 from the U.S.; international callers may telephone 412-902-1009 approximately 15 minutes before the call. CEDAR KNOLLS, N.J., March 25, 2020 /PRNewswire/ [...]
    MYOS RENS Technology Announces Date of Fourth Quarter 2019 Financial Results, Conference Call and Webcast March 19, 2020
    CEDAR KNOLLS, N.J., March 19, 2020 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition made from fertilized egg yolk that helps build lean muscle, will announce financial results for the fourth quarter of 2019 on [...]
    Learn More ›
  • MYOS RENS Technology Q4 2019 Results Conference Call

    Dial-in: 877-407-9120 from the U.S.; international callers may telephone 412-902-1009

    A digital replay will be available by telephone approximately two hours after the completion of the call until April 8, 2020 and may be accessed by dialing 877-660-6853 from the U.S., or 201-612-7415 for international callers using the Conference ID# 13700696.


    International Conference on Frailty and Sarcopenia Research

    Toulouse, France

Stock Snapshot

MYOS Symbol
Market Cap